Created at	Source	Raw Value	Validated value
Aug. 31, 2021, 8:30 p.m.	usa	Area Under the Curve From Day 0-28 (AUC0-d28) of Tocilizumab);Clearance (CL) of Tocilizumab;Maximum Serum Concentration (Cmax) of Tocilizumab;Serum Concentration of C-reactive Protein (CRP) Following Administration of IV TCZ;Serum Concentration of Ferritin Following Administration of IV TCZ;Serum Concentration of Interleukin-6 (IL-6) Following Administration of IV TCZ;Serum Concentration of Soluble Interleukin-6 Receptor (sIL-6R) Following Administration of IV TCZ;Volume of the Central Compartment (Vc) of Tocilizumab	Area Under the Curve From Day 0-28 (AUC0-d28) of Tocilizumab);Clearance (CL) of Tocilizumab;Maximum Serum Concentration (Cmax) of Tocilizumab;Serum Concentration of C-reactive Protein (CRP) Following Administration of IV TCZ;Serum Concentration of Ferritin Following Administration of IV TCZ;Serum Concentration of Interleukin-6 (IL-6) Following Administration of IV TCZ;Serum Concentration of Soluble Interleukin-6 Receptor (sIL-6R) Following Administration of IV TCZ;Volume of the Central Compartment (Vc) of Tocilizumab
Oct. 26, 2020, 11:31 p.m.	usa	Serum Concentration of CRP Following Administration of 4 mg/kg IV TCZ;Serum Concentration of Ferritin Following Administration of 8 mg/kg IV TCZ;Serum Concentration of Ferritin Following Administration of 4 mg/kg IV TCZ;Serum Concentration of sIL-6R Following Administration of 4 mg/kg IV TCZ;Serum Concentration of IL-6 Following Administration of 4 mg/kg IV TCZ;Serum Concentration of interleukin-6 (IL-6) Following Administration of 8 mg/kg IV TCZ;Serum Concentration of C-reactive Protein (CRP) Following Administration of 8 mg/kg IV TCZ;Serum Concentration of Soluble Interleukin-6 Receptor (sIL-6R) Following Administration of 8 mg/kg IV TCZ	Serum Concentration of CRP Following Administration of 4 mg/kg IV TCZ;Serum Concentration of Ferritin Following Administration of 8 mg/kg IV TCZ;Serum Concentration of Ferritin Following Administration of 4 mg/kg IV TCZ;Serum Concentration of sIL-6R Following Administration of 4 mg/kg IV TCZ;Serum Concentration of IL-6 Following Administration of 4 mg/kg IV TCZ;Serum Concentration of interleukin-6 (IL-6) Following Administration of 8 mg/kg IV TCZ;Serum Concentration of C-reactive Protein (CRP) Following Administration of 8 mg/kg IV TCZ;Serum Concentration of Soluble Interleukin-6 Receptor (sIL-6R) Following Administration of 8 mg/kg IV TCZ